{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:27:03Z","timestamp":1794090423434,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ANR-20-COVI-0093-COVIMUNE"],"award-info":[{"award-number":["ANR-20-COVI-0093-COVIMUNE"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["653316"],"award-info":[{"award-number":["653316"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI151758"],"award-info":[{"award-number":["U01AI151758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.isci.2023.106124","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:59:12Z","timestamp":1675375152000},"page":"106124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants"],"prefix":"10.1016","volume":"26","author":[{"given":"Camille","family":"Chauvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurine","family":"Levillayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Roumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Nielly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Karnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Reddy","family":"Bonam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bourgarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Dubost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Le Burel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eble","family":"Mestiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Sene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Galland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Le Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vassord-Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan","family":"Pham-Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Planchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Mouquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Simon-Loriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gilardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anavaj","family":"Sakuntabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.106124_bib1","series-title":"Who Coronavirus (Covid-19) Dashboard","year":"2021"},{"key":"10.1016\/j.isci.2023.106124_bib2","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1038\/s41467-021-25312-0","article-title":"Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery","volume":"12","author":"Feng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2023.106124_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","author":"Kim","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2023.106124_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2023.106124_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2023.106124_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.106124_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection","volume":"386","author":"Nemet","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.106124_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.106124_bib9","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.2174\/0929867328666201209100259","article-title":"The role of interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19","volume":"28","author":"Giannakodimos","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.isci.2023.106124_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-015-0580-y","article-title":"CD27-IgD- memory B cells are modulated by in\u00a0vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis","volume":"17","author":"Mahmood","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2023.106124_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jamainternmed.2021.2209","article-title":"Effectiveness of tocilizumab in patients hospitalized with COVID-19: a follow-up of the CORIMUNO-TOCI-1 randomized clinical trial","volume":"181","author":"Mariette","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.isci.2023.106124_bib13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.106124_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10875-020-00911-6","article-title":"Tocilizumab for severe worsening COVID-19 pneumonia: a propensity score analysis","volume":"41","author":"Roumier","year":"2021","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.106124_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.27221","article-title":"Tocilizumab in systemic lupus erythematosus\u00a0\u2013 safety, preliminary efficacy, and impact on circulating plasma cells","volume":"62","author":"Illei","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2023.106124_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/art.30242","article-title":"In\u00a0vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment","volume":"63","author":"Roll","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2023.106124_bib18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2010.141325","article-title":"Impact of IL-6 receptor inhibition on human memory B cells in\u00a0vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells","volume":"70","author":"Muhammad","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2023.106124_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2023.106124_bib20","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2009-07-230631","article-title":"IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production","volume":"115","author":"Maeda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.isci.2023.106124_bib21","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib22","doi-asserted-by":"crossref","first-page":"611004","DOI":"10.3389\/fimmu.2020.611004","article-title":"B cell subsets as severity-associated signatures in COVID-19 patients","volume":"11","author":"Sosa-Hern\u00e1ndez","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(20)30070-3","article-title":"Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial","volume":"19","author":"Zhang","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2023.106124_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/eji.1830230436","article-title":"Interleukin 6 is not required for antigen-specific antibody responses by human B cells","volume":"23","author":"Costelloe","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.106124_bib26","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/annrheumdis-2012-201950","article-title":"Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis","volume":"71","author":"Mori","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2023.106124_bib27","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar4427","article-title":"Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis","volume":"16","author":"Kapetanovic","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2023.106124_bib28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/1535-7163.MCT-11-0972","article-title":"Sustained remission of multicentric castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody","volume":"11","author":"Galeotti","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2023.106124_bib29","unstructured":"Moura, R.A., Quaresma, C., Vieira, A.R., Gon\u00e7alves, M.J., Polido-Pereira, J., Rom\u00e3o, V.C., Martins, N., Canh\u00e3o, H., and Fonseca, J.E. B-Cell Phenotype and IgD-CD27- Memory B Cells Are Affected by TNF-Inhibitors and Tocilizumab Treatment in Rheumatoid Arthritis. 32"},{"key":"10.1016\/j.isci.2023.106124_bib30","first-page":"720","article-title":"Alterations in T and B cell function persist in convalescent COVID-19 patients","volume":"2","author":"Shuwa","year":"2021","journal-title":"Med. Times"},{"key":"10.1016\/j.isci.2023.106124_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/TP.0000000000002895","article-title":"Impact of tocilizumab (Anti\u2013IL-6R) treatment on immunoglobulins and anti-HLA antibodies in kidney transplant patients with chronic antibody-mediated rejection","volume":"104","author":"Shin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.isci.2023.106124_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102999","article-title":"Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: a prospective cohort study","volume":"60","author":"Masi\u00e1","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2023.106124_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/annrheumdis-2018-214367","article-title":"Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study","volume":"78","author":"Pawar","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2023.106124_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2023.106124_bib35","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.2000717","article-title":"Expansion of SARS-CoV-2\u2013specific antibody-secreting cells and generation of neutralizing antibodies in hospitalized COVID-19 patients","volume":"205","author":"Varnait\u0117","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.106124_bib36","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41467-020-17834-w","article-title":"Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm","volume":"11","author":"Guo","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2023.106124_bib37","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1086\/657158","article-title":"Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults","volume":"202","author":"Lee","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2023.106124_bib38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.immuni.2022.04.002","article-title":"Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant","volume":"55","author":"Sokal","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.106124_bib39","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research (2020)","volume":"20","year":"2020","journal-title":"Lancet Infect. Dis."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223002018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223002018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:57:58Z","timestamp":1778900278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223002018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2589004223002018"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.106124","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.106124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"106124"}}